BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15875658)

  • 1. Does RNA interference have a future as a treatment for HIV-1 induced disease?
    Cullen BR
    AIDS Rev; 2005; 7(1):22-5. PubMed ID: 15875658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference and HIV-1 infection.
    Kanzaki LI; Ornelas SS; Argañaraz ER
    Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
    Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
    Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of HIV-1 replication by RNA interference.
    Lee NS; Rossi JJ
    Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of drug-resistant HIV-1 by RNA interference.
    Huelsmann PM; Rauch P; Allers K; John MJ; Metzner KJ
    Antiviral Res; 2006 Jan; 69(1):1-8. PubMed ID: 16290277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RNA interference and its application in inhibiting HIV-1 infection].
    Wei L; Liu X; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
    Leonard JN; Schaffer DV
    J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis.
    Li Z; Xiong Y; Peng Y; Pan J; Chen Y; Wu X; Hussain S; Tien P; Guo D
    FEBS Lett; 2005 Jun; 579(14):3100-6. PubMed ID: 15913611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
    Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
    J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the sequence space available for HIV-1 evolution.
    ter Brake O; von Eije KJ; Berkhout B
    AIDS; 2008 Sep; 22(14):1875-7. PubMed ID: 18753935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.
    Pomerantz RJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):401-9. PubMed ID: 15577741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects: RNA-based therapies for treatment of HIV infection.
    Scherer L; Rossi JJ; Weinberg MS
    Gene Ther; 2007 Jul; 14(14):1057-64. PubMed ID: 17607313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs.
    He YX; Hua RH; Zhou YJ; Qiu HJ; Tong GZ
    Antiviral Res; 2007 May; 74(2):83-91. PubMed ID: 16730075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
    Wu K; Gong Y; Zhang X; Zhang Y; Mu Y; Liu F; Song D; Zhu Y; Wu J
    Acta Virol; 2005; 49(4):235-41. PubMed ID: 16402680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.
    Sabariegos R; Giménez-Barcons M; Tàpia N; Clotet B; Martínez MA
    J Virol; 2006 Jan; 80(2):571-7. PubMed ID: 16378959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.